LSPW
BMY.RT

Lake Street Private Wealth’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Lake Street Private Wealth’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,486
Closed -$22K – 209
2020
Q4 		$22K Buy
32,486
+20,473
+170% +$43.6K 0.01% 194
2020
Q3 		$27K Buy
+12,013
New +$34.3K 0.01% 160

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Lake Street Private Wealth's BMY.RT Position: Q1 2021 in Review

Lake Street Private Wealth sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 32,486 shares — an estimated $22K sold.

Lake Street Private Wealth first reported a position in BMY.RT in Q3 2020 and held it in 2 quarters. The position peaked at $27K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Lake Street Private Wealth reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Lake Street Private Wealth sold 32,486 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $22K.
  • Lake Street Private Wealth first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q3 2020 and held it in 2 quarters.
  • Lake Street Private Wealth's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $27K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Lake Street Private Wealth's 13F filing for Q1 2021, filed 16 Apr 2021.